clinical trial · NCT03935971
The Effects of Dupilumab on Allergic Contact Dermatitis
Allergic Contact DermatitisDupilumab
brief summary
The aim of this study is to investigate the effects of dupilumab on allergic contact dermatitis.
started
Dec 18, 2019
primary completion
Dec 31, 2024
completion
Mar 31, 2027
last updated
Jul 16, 2026
detailed description
The investigators will recruit 30 patients with allergic contact dermatitis who have not improved with allergen avoidance up to 18 months after patch testing, but where allergic contact dermatitis is still suspected. Subjects will receive 10 weeks of dupilumab, and both clinical data and tissue samples will be assessed.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol